Description
Specialised probiotics support during pregnancy, breastfeeding and infancy.
- Assists baby's behavioural, immune and gastrointestinal health when taken during pregnancy.
- Support maternal flora balance, glucose metabolism and wellbeing.
- 2 in 1 formula that can be used by both mother and baby.
Clinical benefits:
- Assists behavioural complaints in later childhood when taken during pregnancy and infancy.
- The regulation of emotional behaviour and the central GABAergic system may be via the vagus nerve (gut-brain axis).
- LGG® has demonstrated benefits for childhood atopy and immune development.
- LGG® has been shown a reduction in atopy (allergy and eczema) when taken in the last trimester and during infancy. This may be due to an increase in transforming anti-inflammatory growth factor (TGF-B2) in breast milk. TGF-B2 is a key immunoregulatory anti-inflammatory that inhibits IgE synthesis.
- In late pregnancy, supplementing with LGG® assists maternal glucose metabolism
- LGG® and BB12® may help to reduce the occurrence of central weight gain following childbirth.
- LGG®, when given to infants, enhances the relative levels of key bifidobacterium, including B. breve.
- B. longum (BB536) and B. breve (M-16v) are both human residential bacterial strains that have a modulating action on the gut microbiota of pregnant women and their infants.
Each capsule contains: |
|
Lactobacillus rhamnosus (LGG®) | 10 billion CFU (organisms) |
Bifidobacterium animalis ssp lactis (BB-12®) | 5 billion CFU (organisms) |
Bifidobacterium breve (M-16v) | 5 billion CFU (organisms) |
Bifidobacterium longum (BB536) | 5 billion CFU (organisms) |
LGG® is a registered trademark of Chr. Hansen A/S.
Free from animal products, dairy protein, lactose, eggs, gluten, wheat, nuts and soy protein. Free from artificial colours, flavours and preservatives.
- Always read the label. Follow the directions for use.
- If symptoms persist, consult your healthcare professional.
TGA Listed product with Aust L 290545.
Download TGA Public Summary for TGA published information including excipients, which are listed under 'Other Ingredients'.